What is LOPJLB’s current signal on CLRB?

LOPJLB’s latest quantitative signal on Cellectar Biosciences, Inc. (CLRB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CLRB in?

Cellectar Biosciences, Inc. (CLRB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Cellectar Biosciences, Inc. (CLRB) do?

Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Walden…

Where is Cellectar Biosciences, Inc. based / listed?

Cellectar Biosciences, Inc. is based in US, listed on NASDAQ.

Cellectar Biosciences, Inc. (CLRB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.45+3.57%Close

SELLCRISIS · day 13

[SCORES & PROFILE]

FUND: 15
VALUE: 32
GROWTH: 47
GARP: 6
TYPE: Value / Recovery

Composite of Value · Growth · GARP

ROIC-99.4%

REV YoY-

ROE-165.7%

EPS YoY-

ROA-60.9%

GROSS

NET

[VALUATION]

P/E TTM-0.33

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B0.62

P/FCF-

EV/EBITDA0.91

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E5.13

ALTMAN Z-

CURR RATIO6.66

ND/EBITDA-

BETA0.58

Cellectar Biosciences, Inc. (CLRB)

Key stats

Prediction markets

FUNDAMENTALS

Company news